Holdings of TCG Crossover Management, LLC

Name: Holdings of TCG Crossover Management, LLC
Creator: Titelia
License: https://titelia.com/en/sources

· Original filing · Compare with another fund · Report an error

Net assets: -
Positions: 46 in 4 countries
Top ten: 62.5 % of the equity sleeve
Filed on: Mar 31, 2026

Portfolio shape

Positions

Rank	Company	Shares	Value
1	Abivax SA	6,481,085	721.7M $
2	CG oncology Inc	3,670,206	248.4M $
3	Tango Therapeutics Inc	10,531,071	220.3M $
4	Cogent Biosciences Inc	4,946,894	190.4M $
5	CENTESSA PHARMACEUTICALS PLC	4,286,480	170.3M $
6	Dianthus Therapeutics Inc	1,676,624	140.7M $
7	Tyra Biosciences Inc	3,248,980	124.4M $
8	Immunovant Inc	4,457,988	110.7M $
9	BioCryst Pharmaceuticals Inc	11,020,968	104.9M $
10	Mirum Pharmaceuticals Inc	1,062,049	98.1M $
11	Vor BioPharma Inc	5,673,078	96.5M $
12	Spyre Therapeutics Inc	1,900,582	95.9M $
13	Amylyx Pharmaceuticals Inc	6,243,812	86.8M $
14	Disc Medicine Inc	1,341,862	85.8M $
15	Dyne Therapeutics Inc	4,615,144	83.7M $
16	Monte Rosa Therapeutics Inc	4,622,151	76M $
17	Savara Inc	12,362,205	67.5M $
18	Revolution Medicines Inc	576,473	56.1M $
19	Kodiak Sciences Inc	1,445,538	55.1M $
20	LB Pharmaceuticals Inc	1,839,489	45.3M $
21	Surrozen Inc	1,473,101	42.9M $
22	Relay Therapeutics Inc	4,273,356	42.5M $
23	Fulcrum Therapeutics Inc	5,250,000	40.3M $
24	Century Therapeutics Inc	17,754,430	39M $
25	Tectonic Therapeutic Inc	1,204,891	37.2M $
26	Perspective Therapeutics Inc	7,915,567	33M $
27	Xencor Inc	2,452,138	29.6M $
28	Entrada Therapeutics Inc	2,287,500	28.9M $
29	ALX Oncology Holdings Inc	13,011,849	26.1M $
30	Arvinas Inc	2,387,461	25.3M $
31	Janux Therapeutics Inc	1,789,617	24.9M $
32	AGOMAB THERAPEUTICS SA	2,053,233	21.5M $
33	Alector Inc	10,000,000	21.5M $
34	MBX Biosciences Inc	650,000	19.4M $
35	Silence Therapeutics PLC	3,033,560	16M $
36	Liquidia Corp	403,048	15.2M $
37	Ocular Therapeutix Inc	1,647,752	14M $
38	AVALO THERAPEUTICS INC	738,383	11M $
39	Monopar Therapeutics Inc	132,103	7.2M $
40	Context Therapeutics Inc	2,682,696	7M $
41	Structure Therapeutics Inc	140,411	6.8M $
42	Cullinan Therapeutics Inc	406,786	5.8M $
43	Korro Bio Inc	416,301	4.7M $
44	LeonaBio Inc	464,398	4.7M $
45	Upstream Bio Inc	181,063	1.6M $
46	VISTAGEN THERAPEUTICS INC	2,676,580	1.5M $

Download this table: CSV, JSON

Sector breakdown

Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

United States 77.7 %
France 21.2 %
Belgium 0.6 %
United Kingdom 0.5 %

Shares computed on the equity sleeve.

Rank	Country	Lines	Value	Share
1	United States	43	2.6B $	77.71 %
2	France	1	721.7M $	21.19 %
3	Belgium	1	21.5M $	0.63 %
4	United Kingdom	1	16M $	0.47 %

Cite this page

Titelia. "Holdings of TCG Crossover Management, LLC". https://titelia.com/en/funds/US13F1839948